| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |